HGF/c-Met is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-01-23. Numbers and descriptions here follow the published literature rather than marketing material.
Most published reports on dihexa come from cell cultures and animal models. Studies have examined markers of synapse formation, dendritic spine density, and performance on learning tasks in rodents. Proposed mechanisms center on hepatocyte growth factor and its c-Met receptor, with additional attention to angiotensin IV-related pathways. These findings are experimental and have not been confirmed as clinical benefits in humans. The literature often uses different tasks and endpoints, which complicates direct comparison across studies.
Regulatory status differs by country, but dihexa is generally not approved as a therapeutic product. It is often sold as a research chemical, which means purity, labeling, and handling fall outside pharmaceutical drug standards. Some jurisdictions restrict the sale of peptides intended for human consumption. Researchers and suppliers may therefore face different legal requirements depending on location. Import rules and customs enforcement can also affect how such compounds move across borders.
Chemically, dihexa is a short peptide-like molecule with nonstandard components. Its structure includes tyrosine and isoleucine residues linked to a hexanoic acid group and an aminohexanoic amide segment. This design distinguishes it from endogenous angiotensin IV, though the two are discussed together because of shared origins. Published summaries classify it as a small synthetic peptide with lipophilic features that may influence how it crosses biological barriers in experimental systems. Exact conformational details depend on the specific salt or free base form.
Regulatory treatment varies by country. Dihexa does not appear in major pharmacopeias as a licensed therapeutic substance. Suppliers may use labels such as research use only or not for human consumption. Such labels reflect legal and quality-control boundaries rather than evidence of clinical benefit. Importation, possession, and sale can be restricted depending on local laws, and enforcement focuses on claims, distribution channels, and product categories. These rules can change, and they differ from rules for approved medicines.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved as a medicine | Marketed for research use in some regions. |
| Human clinical data | Limited or absent | Most evidence is from cell and animal studies. |
| Primary proposed pathway | HGF/c-Met signaling | Angiotensin IV-related activity also reported. |
| Common study models | Rodent neurons and behavioral tasks | Results may not translate directly to humans. |
| Key uncertainty | Bioavailability and brain exposure | Questions remain about absorption and target engagement. |
In laboratory settings, dihexa is typically handled as a lyophilized peptide powder. Appropriate personal protective equipment and a ventilated workspace are standard practices for weighing and transferring research chemicals. Because the compound lacks regulatory approval for clinical use, it should not be given to people. Institutional safety rules and local regulations govern its acquisition, storage, and disposal. Suppliers often provide a certificate of analysis that lists purity, identity, and batch-specific handling notes.
Dissolution depends on the peptide’s salt form, purity, and the chosen solvent. Dimethyl sulfoxide is commonly used to prepare concentrated stock solutions, while aqueous buffers may show limited solubility. Sonication or gentle warming can sometimes aid dissolution, but excessive heat may promote degradation. Once in solution, the material is generally kept cold and protected from light. Researchers should verify solubility for each lot rather than assuming uniform behavior across suppliers.
Quality control usually combines reverse-phase high-performance liquid chromatography with mass spectrometry. Chromatography estimates purity and detects related impurities, while mass spectrometry supports molecular identity. Nuclear magnetic resonance can provide additional structural confirmation when needed. Stability data for dihexa are limited, and degradation pathways may depend on pH, temperature, and moisture. Open questions include long-term stability in different formulations and the effect of repeated freeze-thaw cycles on measured purity. Such tests help confirm that a batch matches its label before use.
The leading hypothesis for dihexa centers on hepatocyte growth factor (HGF) and its receptor, c-Met. In cell-based assays, dihexa has been reported to potentiate HGF-dependent signaling. That pathway influences cell growth, survival, and motility. Because c-Met signaling is widespread, the proposed mechanism is broad rather than specific to neurons. The exact binding site and stoichiometry remain areas of active investigation, and independent replication is limited. This uncertainty limits firm conclusions about how the compound acts in living organisms.
Animal studies have examined dihexa in models of cognitive impairment, synaptic plasticity, and memory. Some reports describe improved performance on maze or avoidance tasks after administration. These findings are preclinical and often involve small samples, varied routes, and differing formulations. Results in rodents do not establish effects in humans. The absence of published randomized controlled trials in people is a major gap in the evidence base. Observational reports and user accounts do not substitute for controlled clinical data.
Discussion in the literature often separates direct receptor activation from downstream growth-factor modulation. Dihexa is not simply an angiotensin receptor blocker or a classic nootropic drug. Its proposed action may depend on endogenous HGF levels, which vary by tissue and physiological state. Questions remain about brain penetration, metabolic stability, and active metabolites. Reviews note that mechanistic claims should be treated as hypotheses until supported by independent studies. That distinction is important when interpreting promotional claims or early laboratory findings.
== Further reading == Marshall JD, Beck S, Maffei P, Naggert JK (2007). "Alström syndrome". Eur. J. Hum. Genet. 15 (12): 1193–202. doi:10.1038/sj.ejhg.5201933. PMID 17940554. Alfonso Ortigado., et al. "Semaglutide in Alström Syndrome: An Improvement in the Natural Course of Cardiomyopathy". EC Paediatrics 14.7 (2025): 01-07. Berkower C. Voice of the Patient Report [Internet]. Alstrom Syndrome International; 2022 [cited 2024 Aug 22]. Available from: https://www.alstrom.org/wp-content/uploads/2023/05/ASI-EL-PFDD_FINAL_8May23.pdf Knorz VJ, Spalluto C, Lessard M, Purvis TL, Adigun FF, Collin GB, Hanley NA, Wilson DI, Hearn T (2010): Centriolar association of ALMS1 and likely centrosomal functions of the ALMS motif-containing proteins C10orf90 and KIAA1731. Mol Biol Cell (21):3617-3629. Koc E, Bayrak G, Suher M, Ensari C, Aktas D, Ensari A (2006): Rare case of Alstrom syndrome without obesity and with short stature, diagnosed in adulthood. Nephrology11(2):81-84. Roy A, Patel L, Yuan M, O'Shea C, Alvior AMB, Charalambides M, Moxon D, Baig S, Bunting KV, Gehmlich K, Geberhiwot T, Steeds RP. Defining the cardiovascular phenotype of adults with Alström syndrome. Int J Cardiol. 2024 Aug 15;409:132212. doi: 10.1016/j.ijcard.2024.132212. Epub 2024 May 26. PMID 38806112.
== The Chemical Basis of Growth and Senescence (1923) == In between 1916 and 1920 Robertson published a series of 16 papers in the Journal of Biological Chemistry under the title Experimental Studies on Growth. The papers became the foundation of his (1923) textbook, The Chemical Basis of Growth and Senescence (BR.39): a work that examined the "self-accelerated" natural processes of growth and aging in plants, animals, and humans (as they were understood at that time). Using mathematical principles, Robertson employed an S-Curve (a.k.a. 'sigmoid curve') (p.5) to demonstrate both the "autokinetic phase" of a "self-accelerated" growth process, "during which the rate of growth is continuously increasing" (p.4), and its "autostatic phase", "during which the rate of growth is decreasing" (p.4). Drawing an analogy to the autocatalyzed chemical reactions of Wilhelm Ostwald (father of his Berkeley colleague Wolfgang Ostwald), Robertson referred to these "self-accelerated" processes as being "autocatalyzed" (p.6). As Lee and Hanson observed (in 1947), "[Robertson's] theory of autocatalytic control over growth ... has been variously rejected, acknowledged and accepted by investigators" (RL.1, p.53).
Such programs typically relate to youth, schools, public health, and social assistance. Second, Article 28(2) of the Basic Law guarantees the municipalities "the right to regulate on their own responsibility all the affairs of the local community within the limits set by law". Under this broad statement of competence, local governments can justify a wide range of activities. For instance, many municipalities develop and expand the economic infrastructure of their communities through the development of industrial trading estates. Local authorities foster cultural activities by supporting local artists, building arts centres, and by holding fairs. Local government also provides public utilities, such as gas and electricity, as well as public transportation. The majority of the funding for municipalities is provided by higher levels of government rather than from taxes raised and collected directly by themselves. In five of the German states, there are unincorporated areas, in many cases unpopulated forest and mountain areas, but also four Bavarian lakes that are not part of any municipality. As of 1 January 2005, there were 246 such areas, with a total area of 4167.66 km2 or 1.2% of the total area of Germany. Only four unincorporated areas are populated, with a total population of around 2,000. The table below provides an overview.
Initiatives since 2007 made English medium education mandatory nationwide. Following a 2012 attack on activist Malala Yousafzai by the Taliban, she became the youngest Nobel laureate for her education advocacy. Reforms in 2013 mandated Chinese language courses in Sindh, reflecting China's growing influence. As of 2018, Pakistan's literacy rate stands at 62.3%, with significant regional and gender disparities. Government initiatives, including computer literacy since 1995, aim to eradicate illiteracy, targeting 100% enrollment among primary school-age children and an ~86% literacy rate by 2015. Pakistan allocates 2.3% of its GDP to education, among the lowest in South Asia.
Sources: en.wikipedia.org
He had been placed on the Committee at the insistence of his friend, Churchill, and proved unimpressed with the team's work. When he visited the site, he was upset by the crude conditions, and apparently, by the box lunch he had to eat. Lindemann strongly advocated the use of infrared systems for detection and tracking and numerous observers have noted Lindemann's continual interference with radar. As Bowen put it,
German is the official and predominantly spoken language in Germany. It is one of 24 official and working languages of the European Union, and one of the three procedural languages of the European Commission, alongside English and French. German is the most widely spoken first language in the European Union, with around 100 million native speakers. Recognised native minority languages in Germany are Danish, Low German, Low Rhenish, Sorbian, Romani, North Frisian and Saterland Frisian; they are officially protected by the European Charter for Regional or Minority Languages. The most used immigrant languages are Turkish, Arabic, Kurdish, Polish, Italian, Greek, Spanish, Serbo-Croatian, Bulgarian and other Balkan languages, as well as Russian. Germans are typically multilingual: 74% of German citizens claim to be able to communicate in at least one foreign language and 35% in at least two.
==== Congenital abnormalities ==== Cleft lip and palate in combination; cleft lip (cheiloschisis) and cleft palate (palatoschisis), individually. Congenital nasal abnormalities Genetically derived ethnic-nose abnormalities
Sources: en.wikipedia.org
In addition, after a time the silk will lose its stickiness and thus become inefficient at capturing prey. It is common for spiders to eat their own web daily to recoup some of the energy used in spinning. Through ingestion and digestion, the silk proteins are thus recycled. Due to the incredible strength of spider silk, scientists are currently studying it in the hope of creating a super-tough material with similar properties.
== History == Yo-Chi's first store opened in September 2012, in the inner Melbourne suburb of Balaclava. In 2018, Yo-Chi was sold to chef and television personality George Calombaris, under his company MAdE Establishment Group. In 2020, following Calombaris' establishment going into voluntary administration, where Yo-Chi was the only part to survive, it was then sold to Oliver & Riley Allis, sons of Boost Juice founder Janine Allis. The brothers were just 23 and 21 years old respectively at the time of the sale. There were only four locations at the time. Under the Allis family, the number of stores have rapidly increased, opening their 30th store in June 2024, having 43 locations by March 2025, 53 by June 2025, 56 by August 2025, and opening their 70th store in March 2026. In August 2025, Yo-Chi began their international expansion, opening a store in Singapore and their first UK store in London's Notting Hill in 2026.
oryzae with altered properties were generated by irradiation or by the CRISPR/CAS method. Similarly, mutants of A. sojae with altered properties were generated by a variant of the CRISPR/Cas method or chemical mutagenesis.
Sources: en.wikipedia.org
Published human clinical trial data are limited or absent. Most available evidence comes from laboratory and animal studies. Human safety and efficacy remain unresolved.
Preclinical research has focused on synaptic growth, cognitive performance in animals, and HGF/c-Met signaling. These are experimental findings, not established treatments.
Legality varies by country and intended use. It is commonly sold as a research chemical, and sales for human consumption may be restricted. Local regulations should be checked.
It is a synthetic peptide analog of angiotensin IV studied mainly in laboratory and animal research. It is not an approved medicine. Human clinical data are limited.